PneumoIQ™ Enter

Learn more about pneumococcal disease with this informative interactive site.

This site is intended only for residents of the United States.

If you are a resident of a country other than the United States, please visit Wyeth Worldwide to find information about our offices around the globe.

Wyeth
Find out more information about all Wyeth products.

Prevnar®; Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein); The first pneumococcal conjugate vaccine
Help Protect Your Child. What you should know about vaccination. - This site is intended for U.S. residents only. Please scroll down to see Important Safety Information. Important Safety Information

Adobe Flash Player Required; Certain portions of the PREVNAR website require the latest version of the free Adobe Flash Player. Click on the button to the right to download the latest player. Get Adobe Flash Player

Prevnar® Dosing Schedule

Vaccine Schedule for Infants and Toddlers4

2 Months*

4 Months†

6 Months†

12-15 Months‡

Check - 2 Months*

Check - 4 Months†

Check - 5 Months†

Check - 12 to 15 Months‡
  • *May be given as early as 6 weeks of age.
  • †Recommended dosing interval is 4-8 weeks.
  • ‡Should be administered at least 2 months after third dose, and not before 12 months of age.

Vaccine Schedule for Previously Unvaccinated
Older Infants and Children 7 Months of Age4

Age at First Dose

Total Number of Doses

7-11 months

3 doses*

12-23 months

2 doses†

24 months through 9 years

1 dose
  • *Two doses at least 4 weeks apart; third dose after 12 months of age, and at least 2 months after the second dose.
  • †Two doses at least 2 months apart.

Important Safety Information

Ask your child's health care provider about the risks and benefits of Prevnar® and if Prevnar® is right for your child.

In clinical studies, the most frequently reported adverse events included injection site reactions, fever (38ºC/100.4ºF), irritability, drowsiness, restless sleep, decreased appetite, vomiting, diarrhea, and rash.

Risks are associated with all vaccines, including Prevnar®. Hypersensitivity to any vaccine component, including diphtheria toxoid, is a contraindication to its use. Prevnar® does not protect 100% of children vaccinated. Immunization with Prevnar® does not substitute for routine diphtheria immunization.

Please see Prescribing Information.